Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -25.73% is 60% above its 5-year average of -64.97%, near the high end of its 5-year range (-156.21%–-25.73%).
As of the fiscal period ended Tuesday, June 30, 2026. 31.69% above its 12-month average of -37.67%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -25.73%.
RETURN ON INVESTED CAPITAL (ROIC)
-25.73%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-37.67%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-46.94%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-64.97%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+31.69%
CURRENT VS 3Y AVG
+45.19%
CURRENT VS 5Y AVG
+60.40%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.73%
median of 709 covered companies
CURRENT VS SECTOR MEDIAN
+23.71%
vs the sector median at left
Biodesix, Inc.
Market Cap
$229.96M
Return on Invested Capital (ROIC)
-25.73%
TTM Avg
-37.67%
3Y Avg
-46.94%
5Y Avg
-64.97%
Market Cap
$229.43M
Return on Invested Capital (ROIC)
-61.03%
TTM Avg
-35.41%
3Y Avg
-48.95%
5Y Avg
-41.87%
Market Cap
$234.56M
Return on Invested Capital (ROIC)
-28.14%
TTM Avg
-28.34%
3Y Avg
-154.06%
5Y Avg
-154.06%
Market Cap
$235.18M
Return on Invested Capital (ROIC)
-16.87%
TTM Avg
-43.46%
3Y Avg
-51.45%
5Y Avg
-53.92%
Market Cap
$223.25M
Return on Invested Capital (ROIC)
-36.49%
TTM Avg
-7.39%
3Y Avg
-25.88%
5Y Avg
-24.07%
Market Cap
$236.81M
Return on Invested Capital (ROIC)
1.38%
TTM Avg
-1.85%
3Y Avg
-13.83%
5Y Avg
-10.66%
Market Cap
$239.19M
Return on Invested Capital (ROIC)
-25.38%
TTM Avg
-99.58%
3Y Avg
-69.59%
5Y Avg
-61.10%
Market Cap
$239.98M
Return on Invested Capital (ROIC)
-7.08%
TTM Avg
-12.89%
3Y Avg
-21.42%
5Y Avg
-39.95%
Market Cap
$218.62M
Return on Invested Capital (ROIC)
-71.04%
TTM Avg
-53.65%
3Y Avg
-40.34%
5Y Avg
-35.55%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Biodesix, Inc. (BDSX) | $229.96M | -25.73% | -37.67% | -46.94% | -64.97% |
| Profound Medical Corp. (PROF)vs › | $229.43M | -61.03% | -35.41% | -48.95% | -41.87% |
| BioAge Labs Inc. (BIOA)vs › | $234.56M | -28.14% | -28.34% | -154.06% | -154.06% |
| MacroGenics, Inc. (MGNX)vs › | $235.18M | -16.87% | -43.46% | -51.45% | -53.92% |
| Keros Therapeutics, Inc. (KROS)vs › | $223.25M | -36.49% | -7.39% | -25.88% | -24.07% |
| High Tide Inc. (HITI)vs › | $236.81M | 1.38% | -1.85% | -13.83% | -10.66% |
| InflaRx N.V. (IFRX)vs › | $239.19M | -25.38% | -99.58% | -69.59% | -61.10% |
| Akebia Therapeutics, Inc. (AKBA)vs › | $239.98M | -7.08% | -12.89% | -21.42% | -39.95% |
| Alector, Inc. (ALEC)vs › | $218.62M | -71.04% | -53.65% | -40.34% | -35.55% |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $241.59M | -69.76% | -64.00% | -45.05% | -31.07% |
ROIC
-25.7%
ROE
-303.6%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -25.73% |
| 2026-03-31 | -31.07% |
| 2025-12-31 | -39.64% |
| 2025-09-30 | -45.08% |
| 2025-06-30 | -46.83% |
| 2025-03-31 | -44.61% |
| 2024-12-31 | -41.59% |
| 2024-09-30 | -38.63% |
| 2024-06-30 | -33.84% |
| 2024-03-31 | -64.21% |
| 2023-12-31 | -62.86% |
| 2023-09-30 | -89.25% |
| 2023-06-30 | -104.18% |
| 2023-03-31 | -89.37% |
| 2022-12-31 | -72.15% |
| 2022-09-30 | -120.59% |
| 2022-06-30 | -94.31% |
| 2022-03-31 | -156.21% |
| 2021-12-31 | -86.82% |
| 2021-09-30 | -47.47% |
| 2021-06-30 | -29.97% |
| 2021-03-31 | -19.69% |
| 2020-12-31 | -22.76% |
| 2020-09-30 | -100.16% |
| 2020-06-30 | -74.40% |
| 2019-12-31 | -70.68% |
